about
Better Management of Alcohol Liver Disease Using a 'Microstructured Synbox' System Comprising L. plantarum and EGCGValue addition in the efficacy of conventional antibiotics by Nisin against SalmonellaCatechin suppresses an array of signalling molecules and modulates alcohol-induced endotoxin mediated liver injury in a rat model.Synergism in dual functionality of cryptdin-2 in conjunction with antibiotics against Salmonella.Efficiency of double layered microencapsulated probiotic to modulate proinflammatory molecular markers for the management of alcoholic liver disease.Effect of L. plantarum cell-free extract and co-trimoxazole against Salmonella Typhimurium: a possible adjunct therapy.In vitro and in vivo synergistic effects of cryptdin 2 and ampicillin against Salmonella.Revisiting eukaryotic anti-infective biotherapeutics.Small RNAs: the qualified candidates for gene manipulation in diverse clinical pathologies.Potential of 2, 2'-dipyridyl diselane as an adjunct to antibiotics to manage cadmium-induced antibiotic resistance in Salmonella enterica serovar Typhi Ty2 strain.Improved oral therapeutic potential of nanoencapsulated cryptdin formulation against Salmonella infection.Efficacy of cryptdin-2 as an adjunct to antibiotics from various generations against salmonella.Involvement of caspase-3, lipid peroxidation and TNF-alpha in causing apoptosis of macrophages by coordinately expressed Salmonella phenotype under stress conditions.A gold nanoparticles based immuno-bioprobe for detection of Vi capsular polysaccharide of Salmonella enterica serovar Typhi.Positive effect of probiotic Lactobacillus plantarum in reversing the LPS induced infertility in mouse model.In vitro and in silico comparative evaluation of anti-Acinetobacter baumannii peptides.Remediation of intramacrophageal Shigella dysenteriae type 1 by probiotic lactobacilli isolated from human infants' stool samples55 kDa outer-membrane protein from short-chain fatty acids exposed Salmonella enterica serovar Typhi induces apoptosis in macrophages.Protective efficacy of probiotic alone or in conjunction with a prebiotic in Salmonella-induced liver damage.Phytomodulatory potentials of Aloe vera against Salmonella OmpR-mediated inflammation.Correlation between Congo red binding and contact haemolysin production in Shigella species.Amelioratory effects of zinc supplementation on Salmonella-induced hepatic damage in the murine model.Topical delivery of TRPsiRNA-loaded solid lipid nanoparticles confer reduced pain sensation via TRPV1 silencing, in rats.Management of Staphylococcus Mediated Systemic Infection by Enhancing the Resurging Activity of Co-trimoxazole in Presence of Cryptdin-2.Nisin/β-lactam adjunct therapy against Salmonella enterica serovar Typhimurium: a mechanistic approach.Augmentation of antimicrobial activity of conventional antibiotics by cell-free extract of L. plantarum.Effect of Lactobacillus plantarum and L-arginine against endotoxin-induced liver injury in a rat model.Cryptdin-2: a novel therapeutic agent for experimental Salmonella Typhimurium infection.Potential of Azadirachta indica against Salmonella typhimurium-induced inflammation in BALB/c mice.Modulatory effects of Salmonella LAP-LPS on murine macrophages.Tumour necrosis factor alpha mediated apoptosis in murine macrophages by Salmonella enterica serovar Typhi under oxidative stress.Coordinated expression and immunogenicity of an outer membrane protein from Salmonella enterica serovar Typhi under iron limitation, oxidative stress and anaerobic conditions.Short chain fatty acids influence virulence properties of Salmonella enterica serovar Typhimurium.Protection mediated by antibodies to iron-regulated outer-membrane proteins of S. typhi in a mouse peritonitis model.Immunobiology of lipopolysaccharide (LPS) and LPS-derived immunoconjugates vaccinate mice against Salmonella typhimurium.Tackling Salmonella Persister Cells by Antibiotic-Nisin Combination via Mannitol.Effect of nisin and doxorubicin on DMBA-induced skin carcinogenesis--a possible adjunct therapy.Changes in the electrical properties at an early stage of mouse liver carcinogenesis.Peptides as adjuvants for ampicillin and oxacillin against methicillin-resistant Staphylococcus aureus (MRSA)Efficacy of designer K11 antimicrobial peptide (a hybrid of melittin, cecropin A1 and magainin 2) against Acinetobacter baumannii-infected wounds
P50
Q28468429-325E7AF7-9021-4A30-97AB-8DE9CDB067F2Q28534200-B72C9259-0189-4DC9-8DE4-5E44DDCCEE76Q31018362-A14F0E9F-CD4A-4639-B08A-2EBA418DB134Q33568915-7DF98F0B-7839-4D96-AE8B-E94281D31A13Q33748252-31FCDCEB-2111-4473-A9A5-E3C0CFFD7A54Q34668105-CB90E7E5-94F1-4DC9-A22A-2182B8FDCB1EQ35191401-06AAA310-762A-4BB0-9912-549B5201EA59Q38073892-5FF66FFB-AE08-433B-89B9-032F57457915Q38235029-199CEB30-5603-4621-B270-60D01F69D6A1Q38639537-EA813E9F-05B3-4E58-A89B-07ABA4B9FFBCQ39034688-D3188FC4-CACE-4CA9-84A9-F477BB46EFF0Q40105723-412C1946-15E6-4A42-B4E6-388B2818D02AQ40281050-AB5C47A5-4B39-43DD-B10A-C3B49ABBD371Q40286810-5D347DC1-EF5C-45AF-B8A8-054E9D2E453BQ40793282-97C2622B-2019-4D73-93B1-FC99C37A591EQ40969886-C00A0106-C713-4B2B-9E2F-3C6AA97DC2DFQ42689533-DD9A55CB-646A-4701-AF27-EB31EF76F657Q44391824-F27C952F-37F8-4F15-97C5-1A929F531914Q45982739-53F1CEBF-935E-4286-A192-9FF4A75663CEQ46526691-AAFEC507-B8C9-4EBA-936E-016CD9FF49F7Q46780520-299D86B8-BF0C-4097-866B-9F0B4D842909Q46952507-E606880D-4821-4310-957C-D0FE6FB37D46Q47965414-7F78B3A8-DE8B-481E-AA9B-1942EA0A881BQ48597287-1BF2572E-A1B8-471F-AFAF-C0BBEADA59E6Q50000611-CDBE3A89-0925-4A85-B770-D9716D94980AQ50035103-EEE23B50-3419-43C8-A1D4-5C6307A05CC0Q50035697-E4C1F6FE-C08A-427B-A42D-E037F6BA6715Q50050018-A4052C0C-C04F-44ED-8EA2-3C51DDF90EC2Q50057340-2C739690-DD4F-47C0-B7EB-C9D32E5C145FQ50069949-9A412EBA-AE47-4FB9-9E3C-E1C4F85033CEQ50079034-905CAC1D-C303-4C19-B7DF-13FB0FFE6C12Q50084967-72A03B6F-9F56-4C2A-82D7-7CE75D453672Q50088491-F59D11CD-22F2-4E2D-8438-AF9C91EF7BC2Q50088859-40E27E38-0ACA-49AE-9E44-423D6B7E071DQ50131692-7DD043D6-7E99-4716-ACEC-F5D5852DD2E6Q52590840-A99F3699-2950-4465-BB8B-563872359000Q53218890-474E9974-04AB-4D40-9BD4-25D05A155C88Q53257594-BA5DD816-ED98-489B-899E-D1EBC9C78DA1Q57120472-A965B010-EEB0-4837-BE72-D23FEEC1E609Q57144712-4D7D0FF4-8BB9-4DD2-89A2-DD93847B0D38
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Praveen Rishi
@ast
Praveen Rishi
@en
Praveen Rishi
@es
Praveen Rishi
@nl
type
label
Praveen Rishi
@ast
Praveen Rishi
@en
Praveen Rishi
@es
Praveen Rishi
@nl
prefLabel
Praveen Rishi
@ast
Praveen Rishi
@en
Praveen Rishi
@es
Praveen Rishi
@nl
P106
P1153
6602122868
P31
P496
0000-0001-5425-8064